Skip to main content

BioXcel Therapeutics

New Haven, United States

BioXcel Therapeutics is a clinical stage biopharmaceutical company focused on drug development that utilizes novel artificial intelligence.

$8.0M raised
Mar 2026
Post-IPO Equity

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about BioXcel Therapeutics

How much funding has BioXcel Therapeutics raised?
BioXcel Therapeutics has raised $8.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in March 2026.
Who are BioXcel Therapeutics's investors?
BioXcel Therapeutics's investors include Oaktree Capital Management, Qatar Investment Authority.
Where is BioXcel Therapeutics headquartered?
BioXcel Therapeutics is headquartered in New Haven, United States.
What does BioXcel Therapeutics do?
BioXcel Therapeutics is a clinical stage biopharmaceutical company focused on drug development that utilizes novel artificial intelligence.
What stage is BioXcel Therapeutics at?
BioXcel Therapeutics is at the Post-IPO Equity stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"BioXcel Therapeutics — Funding & Investors." VCBacked, March 10, 2026, https://www.vcbacked.co/company/bioxcel-therapeutics. Accessed July 2, 2026.
APA
VCBacked. (2026). BioXcel Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/bioxcel-therapeutics
Wikipedia (cite web)
{{cite web |title=BioXcel Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/bioxcel-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .